Cullinan Therapeutics (CGEM)'s 30-day implied volatility (IV30) was 59.2% at the close on October 29, 2026, down from 59.8% the day before, against a 52-week range of 42.6% to 148.5%. Its 20-day historical volatility was 74.8%.
Data as of October 29, 2026.